The prognostic relevance of left atrium dilatation is well established, and largely demonstrated, for instance, in the context of chronic kidney diseases. 1 In the current edition of the journal, the correlation between increased central blood pressure, related cardiovascular complications and left atrium structural and functional abnormalities are reported. Speckle tracking echocardiography was used to estimate left atrium reservoir function. An increased central pulse pressure was associated with low left atrial strain and higher left atrium volume index, and left atrium dysfunction. It is proposed that the chronic increase of left atrium afterload could impact significantly on left atrium morphology and function: left atrium reservoir function should be considered as a marker for the diagnosis of heart failure with preserved ejection fraction or atrial fibrillation. This may have also important implication for preventive interventions in these clinical conditions.
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Exercise as a medicine in arterial hypertension: the role of personalised intervention Blood pressure variability has been proposed as a possible adjunctive therapeutic target for reducing cardiovascular risk related to hypertension. 4 Experimental and clinical studies have demonstrated that excessive fluctuations in blood pressure values are independently related to the development of target organ damage. 5 Physical exercise is an important component of a lifestyle approach for preventing and managing hypertension, alone or in combination with pharmacological therapy. 6, 7 A small report is here suggesting that this intervention should be personalised and adapted to each individual. In fact, different exercise modalities elicit very different changes on blood pressure variability while they induce similar reductions of blood pressure values. In particular, continuous exercise training was associated with the most favourable therapeutic profile by reducing both systolic and diastolic blood pressure variability.
Psychological intervention in cardiac rehabilitation: there is room for more evidence Cardiac rehabilitation is a multidisciplinary and multifaceted effort focused on physical training, risk factor management and patient education targeted to minimise the impact of heart disease on patient outcomes and restore physical capacity and health as far as it is possible. 8 In this issue of the journal, a systematic review and meta-analysis on cardiac rehabilitation, controlled trials and controlled cohort studies was conducted to evaluate the additional benefit of psychological interventions, in comparison with exercise-based rehabilitation alone. Psychological endpoints were considered, such as depression, anxiety, quality of life, as well as hard cardiovascular morbidity and cardiovascular and all-cause mortality. Results showed non-significant trends, with small-to-moderate effect sizes, for reducing depression and cardiovascular morbidity, with no evident associations with other outcomes. As the authors rightly point out, there is a number of limitations to these findings, including the low to moderate quality of the included studies, and heterogeneity with respect to the intervention. This conclusion is in keeping with the findings of another recent systematic reviews and metaanalyses, i.e. the presence of only low-to-moderate quality of studies and heterogeneity across studies. 9, 10 One of the major limitations is the inclusion in reported studies of patients who are highly motivated to participate and have less-serious mental health problems, which would dilute the potential effect of rehabilitation combined with psychological intervention.
Age and cardiac rehabilitation: no need to be restrictive A paradoxical situation exists in cardiac rehabilitation. People are living longer and the prevalence of cardiovascular disease increases with age. However, older patients are underrepresented in cardiac rehabilitation programmes despite their disease prevalence: EUROASPIRE found that higher age, female gender and low socioeconomic status were predictors of nonparticipation. 8 Into this paradoxical situation, the EU-CaRE project has been designed to obtain the evidence base to improve, tailor and optimise rehabilitation programmes regarding sustainable effectiveness, costeffectiveness and participation level for patients aged 65 years and above. The results confirmed the need for cardiac rehabilitation in this population as patients had multiple risk factors, with 58% having three or more risk factors. Control of risk factors was suboptimal for many despite a high proportion of patients being on appropriate medications. However, limitation of this analysis was the lack of information concerning measure of frailty, as assessment of frailty in patients attending rehabilitation programmes has been advocated. 11 
Pulmonary arterial hypertension and pregnancy
Pregnancy is contraindicated in women with pulmonary arterial hypertension (PAH), including those with PAH related to congenital heart disease (CHD). The results from a single-centre retrospective design are in keeping with this recommendation. Here it is presented the largest cohort of pregnancies in this population until now and the first that used the current clinical classification of PAH related to CHD according to European Society of Cardiology/European Respiratory Society guidelines for the diagnosis and treatment of pulmonary hypertension. It included the outcomes of pregnancy in 93 patients (94 pregnancies) with PAH-CHD who were admitted for delivery in a tertiary centre during a period of 5.5 years. Interestingly, in more than a third of the cohort the establishment of PAH-CHD diagnosis occurred during pregnancy. In total, 6.4% of pregnant women died, 35.1% developed heart failure and 10.6% experienced a pulmonary hypertension crisis. However, timely referral to tertiary expert care, a multidisciplinary approach and PAH targeted therapies may have majorly contributed to the decrease of mortality in pregnant PAH-CHD patients with respect to previous reports.
Sex-specific associations of prediabetes
In the new era of precision medicine, the investigation of disparities is mandatory to tailor preventive strategies. Mounting evidence supports the existence of substantial sex differences in the microvascular and macrovascular complications of diabetes. Biological differences between men and women can contribute to sex differences in the occurrence and prognosis of diabetes. In this issue, meaningful sex differences in the association between prediabetes and some cardiometabolic outcomes across the diagnostic categories of impaired fasting glucose and impaired glucose tolerance among 8498 Iranian participants in the Teheran Lipid and Glucose Study were found. For example, women were at higher risk of hypertension and coronary artery disease, whereas men were of higher risk of stroke and kidney disease. In addition to traditional cardiovascular risk factors such as obesity, dyslipidaemia, smoking and physical inactivity, alternative risk factors have been evaluated in order to better identify men and women at increased cardiometabolic risk.
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Low education level as a cardiovascular risk factor
Several observational studies in the last two decades have consistently associated socioeconomic factors, including lower education with an increased risk of cardiovascular disease. 15 In this issue, Ariansen et al. have explored to what extent behavioural and biological modifiable risk factors differ in their impact on the educational gradient in premature cardiovascular mortality. To do so, they used three large Norwegian surveys, selecting participants born in the 1930s, 1940s or 1950s and turning 40-45 years at the year of their health survey participation. Out of 360,008 subjects finally evaluated, a progressive improvement in the level of education was accompanied to a reduced premature cardiovascular mortality in more recent birth cohorts. A large proportion (over two-thirds) of the gap in premature deaths between people with the highest and the lowest education was mediated by the modifiable cardiovascular-risk factors, including smoking, systolic blood pressure, total cholesterol, body mass index, triglycerides and physical activity. Although public campaigns attempted to improve the public knowledge on the risks of 'bad behaviours' over the last few decades, recent evidence suggests that low educational levels represent an important barrier to participation. 16 Cardiopulmonary exercise testing indices in heart failure prognosis Cardiopulmonary exercise testing is a proven contemporary diagnostic tool invaluable for evaluating heart failure severity and candidacy for mechanical circulatory support or heart transplantation. 17 Multiple information can be derived from this text in heart failure prognosis. 18, 19 Here Carriere et al. have tested for the first time whether the magnitude of increase in O 2 consumption within the isocapnic buffering domain predicts syndrome severity and prognosis in patients with heart failure and reduced ejection fraction. They observed that this increase correlated with parameters associated to heart failure prognosis, such as peak VO 2 , VE/VCO 2 slope, brain natriuretic peptide and left ventricular ejection fraction, but only at univariate. Its prognostic power was lost at multivariable analysis, suggesting that isocapnic buffering period stratifies heart failure patients, but not more than other prognostic indices (VE/VCO 2 slope in particular).
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
